Ruthenium-based anticancer agents: Focus on mononuclear Ru(II)–arene organometallic scaffolds and Ru(III) non-arene coordination compounds as clinical leads
Narinderjit Singh Sawaran SinghFaculty of Data Science and Information Technology, INTI International University, Persiaran Perdana BBN, Putra Nilai, Nilai 71800, MalaysiaLuma Hussain SalehDepartment of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, IraqG. PadmaPriyaDepartment of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, IndiaSubhashree RayDepartment of Biochemistry, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha-751003, IndiaAmrita PalDepartment of chemistry Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, IndiaVimal AroraUniversity institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, IndiaKhalmurat IlievTashkent State Technical University, Tashkent 100095, UzbekistanZukhra AtamuratovaUrgench State University, Kh. Alimdjan str. 14, Urgench 220100, UzbekistanDavronbek YulchievNational Research University TIIAME, Kori Niyoziy 39, Tashkent 100000Aseel SmeratCentre for Research Impact and Outcome, Chitkara University, Punjab, IndiaShahad Muthana QasimDepartment of Medical Laboratories Technology, Al-Nisour University College, Nisour Seq. Karkh, Baghdad, Iraq
ABI
Abstract
No abstract available.
Topics
Identifiers
Citations and references
Cited by 0114 references
Metrics — AkademScholar · Coming soon